INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of a Class Action Lawsuit & a Lead Plainti...
September 02 2016 - 09:50AM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All persons or entities who purchased or otherwise
acquired securities of Insmed Incorporated (“Insmed” or the
“Company”) (NASDAQ: INSM) between
March 18, 2013 and June 8, 2016.
You are hereby notified that a securities class action
has commenced in the USDC for the District of New Jersey. If you
purchased or otherwise acquired Insmed securities between March 18,
2013 and June 8, 2016, your rights may be affected by this action.
To get more information go to:
http://www.zlk.com/pslra/insmed-incorporated.
The complaint alleges that, throughout the Class Period,
defendants issued false and misleading statements to investors
and/or failed to disclose that: (1) the data supporting Insmed’s
European marketing authorization application (“MAA”) for lead
product candidate ARIKAYCE was not likely to be approved by the
European Medicines Agency (“EMA”) for the treatment of NTM lung
disease, and (2) therefore ARIKAYCE’S approval by the EMA and
subsequent commercialization in Europe were less likely and/or
imminent than Insmed led investors to believe.
On June 8, 2016, Insmed announced it had withdrawn its MAA for
ARIKAYCE from the EMA, revealing that the Committee for Medicinal
Products for Human Use indicated that the phase 2 study did not
provide a sufficient amount of evidence to support an approval.
If you suffered a loss in Insmed you have until September 13, 2016 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://www.zlk.com/pslra/insmed-incorporated.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive experience representing investors
in securities litigation involving financial fraud, and have
recovered hundreds of millions of dollars for aggrieved
shareholders. Attorney advertising. Prior results do not guarantee
similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160902005401/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Insmed (NASDAQ:INSM)
Historical Stock Chart
From Mar 2023 to Mar 2024